Search
for
Sort by
Research 601–630 of 1000+
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Resequencing Analyses Revealed Genetic Diversity and Selection Signatures during Rabbit Breeding and Improvement
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Meeting Report: 68th Montagna Symposium on the Biology of Skin “Decoding Complex Skin Diseases: Integrating Genetics, Genomics, and Disease Biology”
- Investigation of hub genes and immune infiltration in androgenetic alopecia using bioinformatics analysis
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Alopecia Areata: Current Treatments and New Directions
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa
- Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Feather on the Cap of Medicine
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata
- Innovative strategies for the discovery of new drugs against androgenetic alopecia
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results